NCT03993353 2026-02-12Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerUniversity of California, San DiegoPhase 2 Completed7 enrolled 14 charts
NCT03082534 2026-01-28Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaUniversity of California, San DiegoPhase 2 Completed78 enrolled
NCT02882282 2025-10-23Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial NeoplasiaM.D. Anderson Cancer CenterPhase 2 Completed15 enrolled 8 charts
NCT02586207 2025-10-07Pembrolizumab in Combination With CRT for LA-SCCHNSanford HealthPhase 1 Completed59 enrolled 9 charts
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled